Magnetar Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,085
| Closed | -$386K | – | 907 |
|
|
2020
Q3 | $386K | Buy |
+9,085
| New | +$386K | 0.01% | 484 |
|
|
2019
Q4 | – | Sell |
-15,173
| Closed | -$858K | – | 662 |
|
|
2019
Q3 | $858K | Sell |
15,173
-339
| -2% | -$19.2K | 0.02% | 269 |
|
|
2019
Q2 | $864K | Buy |
15,512
+560
| +4% | +$31.2K | 0.02% | 216 |
|
|
2019
Q1 | $755K | Buy |
+14,952
| New | +$755K | 0.02% | 197 |
|
|
2018
Q4 | – | Sell |
-4,068
| Closed | -$282K | – | 522 |
|
|
2018
Q3 | $282K | Buy |
4,068
+761
| +23% | +$52.8K | 0.01% | 351 |
|
|
2018
Q2 | $250K | Sell |
3,307
-1,235
| -27% | -$93.4K | ﹤0.01% | 425 |
|
|
2018
Q1 | $239K | Buy |
4,542
+332
| +8% | +$17.5K | ﹤0.01% | 493 |
|
|
2017
Q4 | $225K | Buy |
+4,210
| New | +$225K | ﹤0.01% | 587 |
|
|
2017
Q3 | – | Sell |
-8,258
| Closed | -$651K | – | 936 |
|
|
2017
Q2 | $651K | Buy |
8,258
+2,029
| +33% | +$160K | 0.01% | 440 |
|
|
2017
Q1 | $517K | Buy |
+6,229
| New | +$517K | 0.01% | 455 |
|